Sanofi (SNY) Change in Working Capital (2009 - 2026)

Sanofi (SNY) has 18 years of Change in Working Capital data on file, last reported at -$406.2 million in Q1 2026.

• Quarterly Change in Working Capital fell 302.3% year-over-year to -$406.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 272.09% YoY) and the FY2025 annual result came in at $317.8 million, up 337.33% from the prior year.
• Change in Working Capital declined to -$406.2 million in Q1 2026 per SNY's latest filing, from $2.4 billion in the prior quarter.
• The five-year high for Change in Working Capital was $2.4 billion in Q4 2025, with the low at -$2.6 billion in Q3 2024.
• Average Change in Working Capital over 5 years is -$184.1 million, with a median of -$253.6 million recorded in 2026.
• Year-over-year, Change in Working Capital slumped 343.26% in 2024 and jumped 550.12% in 2025.
• Sanofi's Change in Working Capital stood at -$486.7 million in 2022, then surged by 145.77% to $222.7 million in 2023, then tumbled by 343.26% to -$541.8 million in 2024, then jumped by 550.12% to $2.4 billion in 2025, then plunged by 116.66% to -$406.2 million in 2026.
• Business Quant data shows SNY's Change in Working Capital at -$406.2 million in Q1 2026, $2.4 billion in Q4 2025, and $35.1 million in Q3 2025.